Journals / Sabuncuoglu Serefeddin Health Sciences / 2026 / Cilt: 8 Sayı: 1

WHAT IS THE NEW BIOMARKER CALLED ZONULIN?

Yeni Biyobelirteç Zonulin Nedir?

Esmanur Fil Baş(Sinop Ayancık Devlet Hastanesi)0000-0002-2419-1142
Pages
43–48
Publication Date
2026-04-29
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Zonulin, which appears to be a molecule that can be used in the diagnosis and monitoring of many such diseases, is considered a promising biomarker that may change the course of clinical practice in the follow-up of numerous disorders in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The human intestine, one of the body’s largest barriers against potential external factors, performs this function through the tight junction elements between intestinal epithelial cells.
📊
Key Findings & Data:Although more than 150 molecular components are known to form these tight connections, “zonulin” is the only identified endogenous molecule.
💡
Conclusion & Impact:Zonulin, which appears to be a molecule that can be used in the diagnosis and monitoring of many such diseases, is considered a promising biomarker that may change the course of clinical practice in the follow-up of numerous disorders in the future.
🔬Design:Derleme
📍Scope:Comprehensive Sample
⚙️Variables:Zonulin · Biyobelirteç · Sıkı Bağlantı

Abstract

The human intestine, one of the body’s largest barriers against potential external factors, performs this function through the tight junction elements between intestinal epithelial cells. Although more than 150 molecular components are known to form these tight connections, “zonulin” is the only identified endogenous molecule. Zonulin levels have been observed to increase in situations where intestinal permeability rises, as well as in conditions such as intense bacterial exposure, gluten enteropathy, various autoimmune diseases, and neurodevelopmental disorders. Zonulin, which appears to be a molecule that can be used in the diagnosis and monitoring of many such diseases, is considered a promising biomarker that may change the course of clinical practice in the follow-up of numerous disorders in the future.

Özet

İnsan bağırsağı; vücudumuzun olası dış etkenlere yönelik en büyük bariyerlerinden olmakla beraber, bu görevi intestinal epitel hücreleri arasındaki"tight junction” (sıkı bağlantı) elemanlarıyla gerçekleştirmektedir. Bu sıkı bağlantıyı oluşturan 150’nin üstünde moleküler komponent bulunmakla beraber, saptanmış tek endojen molekül zonulindir. Barsak permeabilitesinin arttığı durumda arttığı görülen zonulin molekülünün; yoğun bakteri maruziyeti, gluten enteropatisi, birçok otoimmün hastalık ve nörogelişimsel bozuklukla birlikte yükseldiği görülmüştür. Bu ve benzeri birçok hastalığın tanı ve takibinde kullanılabilecek bir molekül olduğu görülen zonulinin; gelecekteki kullanımıyla, klinik pratikte birçok hastalığın takibi için rutin izlemi değiştirebilecek bir molekül olduğu düşünülmektedir.

🔖

Cite This Article

Baş, E. F. (2026). WHAT IS THE NEW BIOMARKER CALLED ZONULIN?. Sabuncuoglu Serefeddin Health Sciences, Cilt: 8 Sayı: 1, 43–48. https://doi.org/10.55895/sshs.1836277

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (59)

  1. Ajamian, M., Steer, D., Rosella, G., & Gibson, P. R. (2019). Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PloS one, 14(1), e0210728. https://doi.org/10.1371/journal.pone.0210728
  2. Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006). Alterations in intestinal permeability. Gut, 55(10), 1512-1520. https://doi.org/10.1136/gut.2005.085373
  3. Buhner, S., Buning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A.,. & Lochs, H. (2006). Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?. Gut, 55(3), 342-347. https://doi.org/10.1136/gut.2005.065557
  4. Camara-Lemarroy, C. R., Silva, C., Greenfield, J., Liu, W. Q., Metz, L. M., & Yong, V. W. (2020). Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity. Multiple Sclerosis Journal, 26(11), 1340-1350. https://doi.org/10.1177/1352458519863133
  5. Camilleri, M., & Gorman, H. (2007). Intestinal permeability and irritable bowel syndrome. Neurogastroenterology & Motility, 19(7), 545-552. https://doi.org/10.1111/j.1365-2982.2007.00925.x
  6. Carratù, R., Secondulfo, M., De Magistris, L., Iafusco, D., Urio, A., Carbone, M. G.,. & Prisco, F. (1999). Altered intestinal permeability to mannitol in diabetes mellitus type I. Journal of pediatric gastroenterology and nutrition, 28(3), 264-269. https://doi.org/10.1097/00005176-199903000-00010
  7. Caviglia, G. P., Dughera, F., Ribaldone, D. G., Rosso, C., Abate, M. L., Pellicano, R.,. & Astegiano, M. (2019). Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva medica, 110, 95-100. https://doi.org/10.23736/s0026-4806.18.05787-7
  8. Chieppa, M., Rescigno, M., Huang, A. Y., & Germain, R. N. (2006). Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. The Journal of experimental medicine, 203(13), 2841-2852. https://doi.org/10.1084/jem.20061884
  9. Clemente, M. G., De Virgiliis, S., Kang, J. S., Macatagney, R., Musu, M. P., Di Pierro, M. R.,. & Fasano, A. (2003). Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut, 52(2), 218-223. https://doi.org/10.1136/gut.52.2.218
  10. Díaz-Coránguez, M., Segovia, J., López-Ornelas, A., Puerta-Guardo, H., Ludert, J., Chávez, B.,. & González-Mariscal, L. (2013). Transmigration of neural stem cells across the blood brain barrier induced by glioma cells. PloS one, 8(4), e60655. https://doi.org/10.1371/journal.pone.0060655
  11. Drago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M.,. & Fasano, A. (2006). Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian journal of gastroenterology, 41(4), 408-419. https://doi.org/10.1080/00365520500235334
  12. El Asmar, R., Panigrahi, P., Bamford, P., Berti, I., Not, T., Coppa, G. V.,. & Fasano, A. (2002). Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology, 123(5), 1607-1615. https://doi.org/10.1053/gast.2002.36578
  13. Falszewska, A., Szajewska, H., & Dziechciarz, P. (2018). Diagnostic accuracy of three clinical dehydration scales: a systematic review. Archives of Disease in Childhood, 103(4), 383-388. https://doi.org/10.1136/archdischild-2017-313762
  14. Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., & Goldblum, S. E. (2000). Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. The Lancet, 355(9214), 1518-1519. https://doi.org/10.1016/s0140-6736(00)02169-3
  15. Fasano A. (2012). Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 10(10), 1096–1100. https://doi.org/10.1016/j.cgh.2012.08.012
  16. Fasano A. (2020). All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research, 9, F1000 Faculty Rev-69. https://doi.org/10.12688/f1000research.20510.1
  17. Fasano, A. (2011). Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiological reviews, 91 1, 151-75. https://doi.org/10.1152/physrev.00003.2008
  18. Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., & Tsukita, S. (1993). Occludin: a novel integral membrane protein localizing at tight junctions. The Journal of Cell Biology, 123(6 Pt 2), 1777-1788. https://doi.org/10.1083/jcb.123.6.1777
  19. Gharial, J., Laving, A., & Were, F. (2017). Racecadotril for the treatment of severe acute watery diarrhoea in children admitted to a tertiary hospital in Kenya. BMJ Open Gastroenterology, 4(1). https://doi.org/10.1136/bmjgast-2016-000124
  20. Gopalakrishnan, S., Durai, M., Kitchens, K., Tamiz, A. P., Somerville, R., Ginski, M.,. & Pandey, N. B. (2012). Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides, 35(1), 86-94. https://doi.org/10.1016/j.peptides.2012.02.015
  21. Gorelick, M. H., Shaw, K. N., & Murphy, K. O. (1997). Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics, 99(5), e6-e6. https://doi.org/10.1542/peds.99.5.e6
  22. Higashi, T., Tokuda, S., Kitajiri, S. I., Masuda, S., Nakamura, H., Oda, Y., & Furuse, M. (2013). Analysis of the ‘angulin’proteins LSR, ILDR1 and ILDR2–tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis. Journal of cell science, 126(4), 966-977. https://doi.org/10.1242/jcs.116442
  23. Ikenouchi, J., Furuse, M., Furuse, K., Sasaki, H., Tsukita, S., & Tsukita, S. (2005). Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. The Journal of cell biology, 171(6), 939-945. https://doi.org/10.1083/jcb.200510043
  24. Itoh, M., Nagafuchi, A., Yonemura, S., Kitani-Yasuda, T., Tsukita, S., & Tsukita, S. (1993). The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. The Journal of cell biology, 121(3), 491-502. https://doi.org/10.1083/jcb.121.3.491
  25. Klaus, D. A., Motal, M. C., Burger-Klepp, U., Marschalek, C., Schmidt, E. M., Lebherz-Eichinger, D.,. & Roth, G. A. (2013). Increased plasma zonulin in patients with sepsis. Biochemia medica, 23(1), 107-111. https://doi.org/10.11613/bm.2013.013
  26. Kliegman, R. M., Behrman, R. E., Jenson, H. B., & Stanton, B. M. (2007). Nelson textbook of pediatrics e-book. Elsevier Health Sciences.
  27. Kuzma, J. N., Hagman, D. K., Cromer, G., Breymeyer, K. L., Roth, C. L., Foster-Schubert, K. E., Holte, S. E., Weigle, D. S., &Kratz, M. (2019). Intraindividual Variation in Markers of Intestinal Permeability and Adipose Tissue Inflammation in Healthy Normal-Weight to Obese Adults. Cancer epidemiology, biomarkers &prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 28(3), 610–615.https://doi.org/10.1158/1055-9965.epi-18-0641
  28. Lammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K.,. & Fasano, A. (2008). Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology, 135(1),194-204. https://doi.org/10.1053/j.gastro.2008.03.023
  29. Linsalata, M., Riezzo, G., D’Attoma, B., Clemente, C., Orlando, A., & Russo, F. (2018). Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study. BMC gastroenterology, 18(1), 167. https://doi.org/10.1186/s12876-018-0888-6
  30. Malíčková, K., Francová, I., Lukáš, M., Kolář, M., Králíková, E., Bortlík, M.,. & Zima, T. (2017). Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers. Practical laboratory medicine, 9, 39-44. https://doi.org/10.1016/j.plabm.2017.09.001
  31. Martìn-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C., Stoppacciaro, A., Ruco, L., Villa, A., Simmons, D., &Dejana, E. (1998). Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. The Journal of cell biology, 142(1), 117–127. https://doi.org/10.1083/jcb.142.1.117
  32. Nouri, M., Bredberg, A., Weström, B., & Lavasani, S. (2014). Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PloS one, 9(9), e106335. https://doi.org/10.1371/journal.pone.0106335
  33. Olszanecka-Glinianowicz, M., Chudek, J., Kocełak, P., Szromek, A., & Zahorska-Markiewicz, B. (2011). Body fat changes and activity of tumor necrosis factor α system—a 5-year follow-up study. Metabolism, 60(4), 531-536. https://doi.org/10.1016/j.metabol.2010.04.023
  34. Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M. S., Grailer, J. J.,. & Ward, P. A. (2013). Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. American Journal of Physiology-Lung Cellular and Molecular Physiology, 304(12), L863-L872. https://doi.org/10.1152/ajplung.00196.2012
  35. Sapone, A., De Magistris, L., Pietzak, M., Clemente, M. G., Tripathi, A., Cucca, F.,. & Fasano, A. (2006). Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes, 55(5),1443-1449. https://doi.org/10.2337/db05-1593
  36. Singh, P., Silvester, J., Chen, X., Xu, H., Sawhney, V., Rangan, V.,. & Lembo, A. (2019). Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D. United European gastroenterology journal, 7(5), 709-715. https://doi.org/10.1177/2050640619826419
  37. Thomas, K. E., Sapone, A., Fasano, A., & Vogel, S. N. (2006). Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. The Journal of Immunology, 176(4), 2512-2521. https://doi.org/10.4049/jimmunol.176.4.2512
  38. Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S.,. & Fasano, A. (2009). Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences, 106(39), 16799-16804. https://doi.org/10.1073/pnas.0906773106
  39. Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nature reviews immunology, 9(11), 799-809. https://doi.org/10.1038/nri2653
  40. Vanuytsel, T., Vermeire, S., & Cleynen, I. (2013). The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue barriers, 1(5), e27321. https://doi.org/10.4161/tisb.27321
  41. Vojdani, A., Vojdani, E., & Kharrazian, D. (2017). Fluctuation of zonulin levels in blood vs stability of antibodies. World journal of gastroenterology, 23(31), 5669. https://doi.org/10.3748/wjg.v23.i31.5669
  42. Wang, X., Li, M. M., Niu, Y., Zhang, X., Yin, J. B., Zhao, C. J., & Wang, R. T. (2019). Serum zonulin in HBV‐associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Disease Markers, 2019(1), 5945721. https://doi.org/10.1155/2019/5945721
  43. Yao, Z., Mates, J. M., Cheplowitz, A. M., Hammer, L. P., Maiseyeu, A., Phillips, G. S.,. & Ganesan, L. P. (2016). Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein. The Journal of immunology, 197(6), 2390-2399. https://doi.org/10.4049/jimmunol.1600702
  44. Buhner, S., Buning, C., Genschel, J., Kling, K., Herrmann, D., Dignass, A.,. & Lochs, H. (2006). Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?. Gut, 55(3), 342-347. https://doi.org/10.1136/gut.2005.065557
  45. Carratù, R., Secondulfo, M., De Magistris, L., Iafusco, D., Urio, A., Carbone, M. G.,. & Prisco, F. (1999). Altered intestinal permeability to mannitol in diabetes mellitus type I. Journal of pediatric gastroenterology and nutrition, 28(3), 264-269. https://doi.org/10.1097/00005176-199903000-00010
  46. Caviglia, G. P., Dughera, F., Ribaldone, D. G., Rosso, C., Abate, M. L., Pellicano, R.,. & Astegiano, M. (2019). Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva medica, 110, 95-100. https://doi.org/10.23736/s0026-4806.18.05787-7
  47. Clemente, M. G., De Virgiliis, S., Kang, J. S., Macatagney, R., Musu, M. P., Di Pierro, M. R.,. & Fasano, A. (2003). Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut, 52(2), 218-223. https://doi.org/10.1136/gut.52.2.218
  48. Díaz-Coránguez, M., Segovia, J., López-Ornelas, A., Puerta-Guardo, H., Ludert, J., Chávez, B.,. & González-Mariscal, L. (2013). Transmigration of neural stem cells across the blood brain barrier induced by glioma cells. PloS one, 8(4), e60655. https://doi.org/10.1371/journal.pone.0060655
  49. Drago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M.,. & Fasano, A. (2006). Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scandinavian journal of gastroenterology, 41(4), 408-419. https://doi.org/10.1080/00365520500235334
  50. El Asmar, R., Panigrahi, P., Bamford, P., Berti, I., Not, T., Coppa, G. V.,. & Fasano, A. (2002). Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology, 123(5), 1607-1615. https://doi.org/10.1053/gast.2002.36578
  51. Gopalakrishnan, S., Durai, M., Kitchens, K., Tamiz, A. P., Somerville, R., Ginski, M.,. & Pandey, N. B. (2012). Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides, 35(1), 86-94. https://doi.org/10.1016/j.peptides.2012.02.015
  52. Klaus, D. A., Motal, M. C., Burger-Klepp, U., Marschalek, C., Schmidt, E. M., Lebherz-Eichinger, D.,. & Roth, G. A. (2013). Increased plasma zonulin in patients with sepsis. Biochemia medica, 23(1), 107-111. https://doi.org/10.11613/bm.2013.013
  53. Lammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K.,. & Fasano, A. (2008). Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology, 135(1),194-204. https://doi.org/10.1053/j.gastro.2008.03.023
  54. Malíčková, K., Francová, I., Lukáš, M., Kolář, M., Králíková, E., Bortlík, M.,. & Zima, T. (2017). Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers. Practical laboratory medicine, 9, 39-44. https://doi.org/10.1016/j.plabm.2017.09.001
  55. Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M. S., Grailer, J. J.,. & Ward, P. A. (2013). Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. American Journal of Physiology-Lung Cellular and Molecular Physiology, 304(12), L863-L872. https://doi.org/10.1152/ajplung.00196.2012
  56. Sapone, A., De Magistris, L., Pietzak, M., Clemente, M. G., Tripathi, A., Cucca, F.,. & Fasano, A. (2006). Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes, 55(5),1443-1449. https://doi.org/10.2337/db05-1593
  57. Singh, P., Silvester, J., Chen, X., Xu, H., Sawhney, V., Rangan, V.,. & Lembo, A. (2019). Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D. United European gastroenterology journal, 7(5), 709-715. https://doi.org/10.1177/2050640619826419
  58. Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S.,. & Fasano, A. (2009). Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proceedings of the National Academy of Sciences, 106(39), 16799-16804. https://doi.org/10.1073/pnas.0906773106
  59. Yao, Z., Mates, J. M., Cheplowitz, A. M., Hammer, L. P., Maiseyeu, A., Phillips, G. S.,. & Ganesan, L. P. (2016). Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein. The Journal of immunology, 197(6), 2390-2399. https://doi.org/10.4049/jimmunol.1600702